MSH6 and neoplasm: MLH1- and MSH2-deficient tumours are characterised by both mono- and dinucleotide repeat instability, whereas the level of MSI is lower in MSH6-deficient tumours (Bhattacharyya et al, 1995; Papadopoulos et al, 1995).